Header Logo

Erin Farlow

Concepts (47)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
4
2011
244
0.730
Why?
Lung Neoplasms
4
2011
555
0.610
Why?
Autoantibodies
2
2010
81
0.420
Why?
Early Detection of Cancer
2
2010
104
0.400
Why?
Blood Chemical Analysis
1
2010
17
0.360
Why?
Hematologic Tests
1
2010
6
0.350
Why?
Protein Array Analysis
1
2010
10
0.350
Why?
Algorithms
3
2010
371
0.170
Why?
Biomarkers, Tumor
2
2010
202
0.160
Why?
Cohort Studies
3
2011
1890
0.090
Why?
Neoadjuvant Therapy
1
2011
66
0.090
Why?
Serum
1
2010
7
0.090
Why?
Pneumonectomy
1
2011
77
0.090
Why?
Antibodies, Neoplasm
1
2010
13
0.090
Why?
Antigens, Neoplasm
1
2010
39
0.090
Why?
Lymphatic Metastasis
1
2010
90
0.090
Why?
Cell Line, Tumor
1
2010
249
0.080
Why?
Proteomics
1
2010
92
0.080
Why?
Mediastinal Neoplasms
1
2009
11
0.080
Why?
Adenocarcinoma
1
2010
145
0.080
Why?
Gastrointestinal Stromal Tumors
1
2009
30
0.080
Why?
Case-Control Studies
1
2010
585
0.080
Why?
Esophageal Neoplasms
1
2009
53
0.080
Why?
Aged, 80 and over
2
2010
4846
0.060
Why?
Adult
3
2011
8036
0.060
Why?
Humans
5
2011
28117
0.050
Why?
Middle Aged
3
2011
9188
0.050
Why?
Aged
3
2011
9223
0.050
Why?
Male
4
2011
15173
0.050
Why?
Female
3
2011
15583
0.040
Why?
Radiotherapy, Adjuvant
1
2011
52
0.020
Why?
Treatment Outcome
2
2011
3531
0.020
Why?
Chemotherapy, Adjuvant
1
2011
81
0.020
Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
10
0.020
Why?
Tandem Mass Spectrometry
1
2010
21
0.020
Why?
Kaplan-Meier Estimate
1
2011
178
0.020
Why?
Survival Analysis
1
2011
265
0.020
Why?
Analysis of Variance
1
2011
275
0.020
Why?
Multivariate Analysis
1
2011
321
0.020
Why?
Proportional Hazards Models
1
2011
344
0.020
Why?
Neoplasm Staging
1
2011
372
0.020
Why?
Risk Assessment
1
2011
665
0.020
Why?
Follow-Up Studies
1
2011
1811
0.020
Why?
Tomography, X-Ray Computed
1
2009
758
0.010
Why?
Postoperative Complications
1
2011
930
0.010
Why?
Magnetic Resonance Imaging
1
2009
1181
0.010
Why?
Retrospective Studies
1
2011
3537
0.010
Why?
Farlow's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (47)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_